New Strategies to Kill Metabolically-Dormant Cells Directly Bypassing the Need for Active Cellular Processes
Antibiotic therapy failure is often caused by the presence of persister cells, which are metabolically-dormant bacteria capable of surviving exposure to antimicrobials. Under favorable conditions, persisters can resume growth leading to recurrent infections. Moreover, several studies have indicated...
Saved in:
Main Authors: | Karolina Stojowska-Swędrzyńska (Author), Dorota Kuczyńska-Wiśnik (Author), Ewa Laskowska (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
La belle (au bois) dormant
by: López Mozo, Jerónimo
Published: (2018) -
White lesion: A dormant malignancy?
by: Vela D Desai, et al.
Published: (2014) -
Dormant Account Reactivation at Al-Shajar Capital
by: Muhammad Yawar Uz Zaman, et al.
Published: (2019) -
Activating dormant strongyloidiasis secondary to COVID-19 treatment
by: Fahad Alkaabba, et al.
Published: (2022) -
Transcriptomics and Metabolomics Identify Drug Resistance of Dormant Cell in Colorectal Cancer
by: Lang Xie, et al.
Published: (2022)